Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.</li>
<li>In the IPO space, <a href="https://www.smartkarma.com/entities/sino-synergy-hydrogen-energy-technology" target="_blank" data-smartkarma-citation="entities:40364:1" rel="noopener">Sino-Synergy Hydrogen Energy Technology (9663 HK)</a> and <a href="https://www.smartkarma.com/entities/dekon-food-and-agriculture-group" target="_blank" data-smartkarma-citation="entities:36756:1" rel="noopener">Dekon Food</a> didn't do much even as other are lining up to try their luck.</li>
<li>On the placements front, Japan and India flows continue like there is no tomorrow.</li>
</ul>


Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
In the IPO space, Sino-Synergy Hydrogen Energy Technology (9663 HK) and Dekon Food didn't do much even as other are lining up to try their luck.
On the placements front, Japan and India flows continue like there is no tomorrow.


ECM Weekly (10th Dec 2023) - Toyota, Denso, Rakuten, Evolution, IRCON, REPT, UBTech, Entero

APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

Entero Healthcare Solutions Limited / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/entero-healthcare-solutions-limited" target="_blank" data-smartkarma-citation="entities:40156:1" rel="noopener">Entero Healthcare Solutions Limited (2294842D IN)</a>  is looking to raise US$200m in its upcoming India IPO. The bookrunners on the deal are ICICI Securities, DAM Capital, Jefferies, JM Financial, SBI Capital.</li>
<li>Entero Healthcare Solutions (Entero) is a healthcare products distributor in India.</li>
<li>As per the CRISIL report in the DRHP, Entero is amongst the top three healthcare products distributors in India in terms of FY22 revenue.</li>
</ul>



Entero Healthcare Solutions Limited (2294842D IN)  is looking to raise US$200m in its upcoming India IPO. The bookrunners on the deal are ICICI Securities, DAM Capital, Jefferies, JM Financial, SBI Capital.
Entero Healthcare Solutions (Entero) is a healthcare products distributor in India.
As per the CRISIL report in the DRHP, Entero is amongst the top three healthcare products distributors in India in terms of FY22 revenue.


Entero Healthcare Solutions Pre-IPO Tearsheet

India

Entero Healthcare Solutions Private Limited operates as a pharmaceutical products distributor. The Company offers a wide range of medical devices and consumables, as well as patient support and technology solutions. Entero Healthcare Solutions serves retail pharmacies, hospitals, and other health care centers in India.

Entero Healthcare Solutions Limited (2294842D IN)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ECM Weekly (10th Dec 2023) - Toyota, Denso, Rakuten, Evolution, IRCON, REPT, UBTech, Entero

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Sumeet Singh

Entero Healthcare Solutions Pre-IPO Tearsheet

Entero Healthcare Solutions Limited (2294842D IN) is looking to raise US$200m in its upcoming India IPO. The bookrunners are ICICI Securities, DAM...

Clarence Chu